Australian Pharmaceutical Industries

Last updated

Australian Pharmaceutical Industries
Type Subsidiary
IndustryHealth and Beauty
Founded1910
Headquarters Melbourne, Australia
Key people
Peter Robinson, Chairman
Emily Amos, CEO
ProductsPharmaceutical, health and beauty
ServicesWholesale distribution
Manufacturing
Retailing
Parent Wesfarmers
Subsidiaries Priceline
Priceline Pharmacy
Soul Pattinson
Pharmacists Advice
Website www.api.net.au

Australian Pharmaceutical Industriea (API) is a health and beauty company owned by Wesfarmers. It is involved in pharmaceutical distribution, retailing and manufacturing. API is Australia's largest wholesale distributor of pharmaceutical and allied products. [1] The company is involved in retailing through company-owned stores and franchise operations. API operates in the retail health and beauty industry under the following brands: Priceline, Priceline Pharmacy, Soul Pattinson and Pharmacist Advice.

Contents

History

Australian Pharmaceutical Industries was incorporated as Chemists' Co-operative of New South Wales Limited in 1910 and later became known as Wholesale Drug Co before adopting its current name, Australian Pharmaceutical Industries, in 1971. [1] [2]

API acquired Newmans & Western Pharmaceuticals in 1996, and in the following year Amed Supplies Australia was acquired to increase its coverage in medical and surgical products for the hospital market.

API was listed on the Australian Securities Exchange on 16 June 1997. [3]

Chemworld Chemist, a new retail pharmacy banner group, was launched in 1998. API acquired the pharmaceutical wholesaling and manufacturing operations of Washington H Soul Pattinson in 2000.

On 29 October 2001, API purchased Hospital Supplies of Australia, the hospital and medical wholesale distribution business previously owned by the Victorian Healthcare Association. This enabled API to extend its distribution business to the public and private hospital market.[ citation needed ]

On 1 October 2002, API acquired the Interpacific and Interpharma businesses in New Zealand. These companies operated pharmacy wholesaling and retailing in New Zealand, the manufacture of over the counter pharmaceuticals, and wholesale distribution of dental products. This acquisition included Zuellig Pharma, PSM Healthcare and Halas Dental.

The retail brands of Priceline, Priceline Pharmacy, House and Price Attack were acquired on 6 October 2004 from the New Price Retail business. This propelled API to restructure its operations to focus primarily on growing its pharmaceutical distribution, retailing and manufacturing business. The retail led strategy was established by Jeff Sher, the architect of the Priceline Pharmacy model.[ citation needed ]

The next year, API continued to narrow its focus to the pharmacy channel and sold the Halas Dental business.

In 2005, API formed a joint venture with ABN AMRO Capital Advisory Australia. Later that year, the newly formed joint venture then acquired Clifford Hallam Pharmaceuticals.

API sold its New Zealand healthcare and logistics pharmacy business on 14 December 2005. [2]

In 2007, API divested its House and Price Attack brands as part of its retail strategy to focus on Priceline. [1]

In 2018, API made a deal to acquire Clearskincare Clinics for $127.4 million, initially taking a 50.1 per cent stake in the company and increasing to 100 per cent by the end of September 2021. [4]

API was acquired by Wesfarmers for A$774 million in March 2022. [5]

Senior management

The directors of API are as follows: [6] [7]

NameRole
Kenneth W Gunderson-BriggsChairman, Independent non-executive director
Emily AmosCEO [8]
Lee AusburnIndependent non-executive director
Jennifer MacdonaldIndependent non-executive director
Janine EllisIndependent non-executive director
Clive StiffIndependent non-executive director
George TambassisIndependent non-executive director

Controversies

Accounting discrepancies

In 2006 after the implementation of a new IT system, the company found $17.2 million of the company's declared profit had disappeared. [9] Forensic Accountants called in could not find any trace of the money. API chose to write the full amount off their annual profit, causing a net loss of $17.2 million. The company's CEO Jeff Sher resigned after a strategic difference with the board in relation to the treatment of the accounting discrepancy which was proven to have historical significance predating the API acquisition of Priceline.

WorkChoices

The Priceline division shed 32 workers for "operational reasons" under the new WorkChoices Legislation. One of these workers, Andrew Cruickshank, a store layout planner, alleged Priceline fired him on his $101,000 a year contract, replacing him with someone on a $75 000 contract. Priceline claimed otherwise, "It was not the same role...the person wouldn't have been capable of doing the same things". [10] The Australian Industrial Relations Commission ruled in favour of Priceline and found that Cruickshank's termination resulted from Priceline's financial difficulties and the subsequent decision to reorganise its structure. [10] [11]

Sigma takeover

Rival company Sigma Pharmaceuticals attempted to take over API in 2002, but was blocked by the Australian Competition & Consumer Commission. [12] Sigma made another bid in 2006, and discussions continued until 11 December 2006, when Sigma withdrew its bid. [13]

See also

Related Research Articles

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.

<span class="mw-page-title-main">Alliance Healthcare</span> European health products distributor

Alliance Healthcare, formerly Alliance UniChem, is a wholesaler, distributer and retailer of pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres, and hospitals from over 288 distribution centres in 11 countries.

McKesson Europe

McKesson Europe AG, with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year and is represented in 13 countries in Europe. In the 2019 financial year the company achieved a turnover of EUR 21.18 billion. The majority shareholder of the company is the US-based McKesson Corporation, which holds a share of 77.01%. The remaining 22.99% of shares are available on the open market. Kevin Kettler, a US citizen, has been Chairman of McKesson Europe since 1 November 2018.

<span class="mw-page-title-main">McKesson Corporation</span> U.S. healthcare company

McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021.

<span class="mw-page-title-main">Cardinal Health</span> American multinational health care services company

Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical products, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company that was formed by the merger of Bergen Brunswig and AmeriSource in 2001.

<span class="mw-page-title-main">Wesfarmers</span> Australian conglomerate

Wesfarmers Limited is an Australian conglomerate, headquartered in Perth, Western Australia. It has interests predominantly in Australia and New Zealand, operating in retail, chemical, fertiliser, industrial and safety products. With revenue of A$30.8 billion in the 2020 financial year, it is one of Australia's largest companies by revenue. Wesfarmers is also one of the largest private employers in Australia, with approximately 107,000 employees.

<span class="mw-page-title-main">Alliance Boots</span> Pharmaceutical company

Alliance Boots was a multinational pharmacy-led health and beauty group with corporate headquarters in Bern, Switzerland and operational headquarters in Nottingham and Weybridge, United Kingdom.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

<span class="mw-page-title-main">Priceline (Australia)</span> Australian health and beauty retailer owned by Wesfarmers

Priceline is an Australian health and beauty retailer. The Priceline brand has two store types; a traditional Priceline and Priceline Pharmacy. It is owned by Australian Pharmaceutical Industries, which was acquired by Wesfarmers in 2022.

Sigma Healthcare Limited is an Australian, ASX-listed company with a focus on the pharmacy industry. The company has pharmacy operations in retail, wholesale and distribution. From its head office in Clayton, Victoria, Sigma manages over 1,200 branded and independent pharmacies. Sigma Healthcare owns Australian retail pharmacy brands: Amcal, Discount Drug Stores and Guardian Pharmacy. The company also has a presence in the hospital pharmacy services, contract logistics, dose administration aids and other healthcare service adjacencies.

<span class="mw-page-title-main">Coles Group</span> Australian public company

Coles Group Limited is an Australian public company operating several retail chains. Its chief operations are primarily concerned with the sale of food and groceries through its flagship supermarket chain Coles Supermarkets, and the sale of liquor through its Coles Liquor outlets. Since its foundation in Collingwood, Victoria in 1914, Coles has grown to become the second-largest retailer in Australia after its principal rival, Woolworths, in terms of revenue.

Gazal Corporation Limited was a leading Australian branded clothing company and was a listed public company of the Australian Stock Exchange. The company was based in Banksmeadow in the Australian state of New South Wales. Its main business areas were men's, ladies' and children's clothing, and it and its subsidiaries are engaged in the design, manufacture, importation, wholesale and retail of clothing and accessories including business shirts, school wear, surf and casual wear, as well as intimate apparel. The company owned brands such as Mambo Graphics, Davenport and Bisley Workwear and imports brands such as Nautica, Calvin Klein Underwear and held the license for Oroton underwear. The Company had operations in Australasia and Europe. Mambo was sold to Saban Brands in 2015.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin.

Teva API is an international pharmaceutical company headquartered in Israel. Teva API is a stand-alone business unit of Teva Pharmaceutical Industries limited, the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide.

Walgreens Boots Alliance, Inc. (WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies. The company was formed on December 31, 2014, after Walgreens purchased the 55% stake in Alliance Boots that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years. Walgreens became a subsidiary of the newly created company after the transactions were completed. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings of the largest United States corporations by total revenue.

Specialty pharmacy refers to distribution channels designed to handle specialty drugs — pharmaceutical therapies that are either high cost, high complexity and/or high touch. High touch refers to higher degree of complexity in terms of distribution, administration, or patient management which drives up the cost of the drugs. In the early years specialty pharmacy providers attached "high-touch services to their overall price tags" arguing that patients who receive specialty pharmaceuticals "need high levels of ancillary and follow-up care to ensure that the drug spend is not wasted on them." An example of a specialty drug that would only be available through specialty pharmacy is interferon beta-1a (Avonex), a treatment for MS that requires a refrigerated chain of distribution and costs $17,000 a year. Some specialty pharmacies deal in pharmaceuticals that treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease (IBD) or Hepatitis C. "Specialty pharmacies are seen as a reliable distribution channel for expensive drugs, offering patients convenience and lower costs while maximizing insurance reimbursements from those companies that cover the drug. Patients typically pay the same co-payments whether or not their insurers cover the drug." As the market demanded specialization in drug distribution and clinical management of complex therapies, specialized pharma (SP) evolved.„ Specialty pharmacies may handle therapies that are biologics, and are injectable or infused. By 2008 the pharmacy benefit management dominated the specialty pharmacies market having acquired smaller specialty pharmacies. PBMs administer specialty pharmacies in their network and can "negotiate better prices and frequently offer a complete menu of specialty pharmaceuticals and related services to serve as an attractive 'one-stop shop' for health plans and employers."

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, California. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

EBOS Group Limited is the largest marketer, wholesaler, and distributor of medical, and pharmaceutical products in Australasia. It is also a major provider of animal care products.

References

  1. 1 2 3 "Company Profile: API". InvestSMART.
  2. 1 2 "Company Profile: API" Archived 3 October 2009 at the Wayback Machine . CareerOne.
  3. "Company Research: API" Australian Securities Exchange
  4. Blake, Dean (26 June 2018). "API acquires Clearskincare Clinics for $127.4m". Inside Retail. Retrieved 6 June 2023.
  5. "API Acquisition". Wesfarmers . Retrieved 9 June 2022.
  6. "Board of Directors". API website.
  7. "Australian Pharmaceutical Industries Limited 2009 Annual Report" Archived 23 February 2011 at the Wayback Machine . Australian Pharmaceutical Industries.
  8. LaFrenz, Carrie (4 August 2022). "Wesfarmers names head of API after CEO steps down" . Australian Financial Review . Retrieved 19 June 2023.
  9. AIRC confirms expanded exemption to unfair dismissal, McCullough Robertson Lawyers Archived 2 March 2011 at the Wayback Machine
  10. 1 2 Schubert, Misha. "Priceline case puts focus on IR laws", The Age , 25 April 2007.
  11. Godfrey, Kelly & Moulton, Adam. "Employees fail in operational reasons termination claims" Archived 16 April 2011 at the Wayback Machine , Human Resources Leader, 15 May 2007.
  12. ACCC denies authorisation for API – Sigma merger Australian Competition & Consumer Commission
  13. Qantas, banks lift market ABC News